Carmel, IN, United States of America

Wei-Ming Sun

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-Ming Sun. Retrieved from https://idiyas.com/inventor/wei-ming-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wei-Ming Sun and an Innovation in Oligonucleotide Synthesis

Introduction

Wei-Ming Sun is an inventor associated with Eli Lilly and Company in Carmel, Indiana. Sun’s patent work describes an oscillating fluidized-bed approach to oligonucleotide synthesis, designed to improve how reagents contact resin during the process.

Latest Patents

Sun is associated with 1 patent, titled “Oscillating Fluidized Bed Oligonucleotide Synthesizer.” The invention describes building an oligonucleotide on solid-phase resin inside a filter reactor. During synthesis, an activated amidite solution flows up and down through the resin bed, fluidizing or mixing the resin so the reagents can contact it more completely.

The method can fluidize or mix the resin during deblocking, coupling, oxidation, sulfurization, and capping. Reagents drain through a filter at the reactor’s bottom before washing, while a distributor spreads reagents or wash solvents evenly over the resin. The design aims to maintain a flat, channel-free resin bed and supports segmented, integrated washing. It also describes collecting cleaner wash portions for reuse in a later cycle and recycling excess deblocking reagent between phosphoramidite cycles.

Career Highlights

The patent reflects Sun’s work on process and equipment design for solid-phase oligonucleotide synthesis. Its features focus on reagent contact, washing efficiency, and reuse of solvents and reagents.

Collaborations

Sun’s listed coworkers include Martin D. Johnson and Luke P. Webster. The available information identifies Eli Lilly and Company as Sun’s company affiliation.

Conclusion

Wei-Ming Sun’s patent presents a fluidized-bed approach to oligonucleotide synthesis that combines improved resin mixing with strategies for more efficient washing and reagent use.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…